P
Philochem at Festival of Biologics 2026
Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website
Philochem takes part in 4 sessions at Festival of Biologics 2026 in Basel. Its sessions centre on cancer drugs that fuse an antibody to an immune-signalling protein (a cytokine), including late-stage clinical results. It also covers building stable cell lines for antibody production and measuring small charge differences between copies of a fusion protein.
| Organization | Festival of Biologics 2026 Attendance |
|---|---|
P Philochem Otelfingen, Switzerland | |
Philogen's Swiss research subsidiary, developing antibody-cytokine fusions and small-molecule ligands for cancer therapy. | Talk Wed Oct 14 15:10 Talk Wed Oct 14 17:50 Advancing stable cell line development for production of therapeutic antibodies Comparing random gene insertion with placing genes at chosen spots in the genome to get steadier antibody production from cell lines. Talk Thu Oct 15 09:20 Talk Thu Oct 15 11:20 Charge Variants characterization of a noncovalent dimeric fusion protein How to measure the different charged forms of a fusion protein whose two halves are not chemically bonded, unlike a standard antibody. |
Instantly find 20 buyers from Philochem
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction